1. Home
  2. DNLI vs GNW Comparison

DNLI vs GNW Comparison

Compare DNLI & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • GNW
  • Stock Information
  • Founded
  • DNLI 2013
  • GNW 1871
  • Country
  • DNLI United States
  • GNW United States
  • Employees
  • DNLI N/A
  • GNW N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • GNW Life Insurance
  • Sector
  • DNLI Health Care
  • GNW Finance
  • Exchange
  • DNLI Nasdaq
  • GNW Nasdaq
  • Market Cap
  • DNLI 3.3B
  • GNW 3.0B
  • IPO Year
  • DNLI 2017
  • GNW 2004
  • Fundamental
  • Price
  • DNLI $20.84
  • GNW $6.99
  • Analyst Decision
  • DNLI Strong Buy
  • GNW Hold
  • Analyst Count
  • DNLI 11
  • GNW 1
  • Target Price
  • DNLI $40.40
  • GNW $7.00
  • AVG Volume (30 Days)
  • DNLI 867.7K
  • GNW 3.5M
  • Earning Date
  • DNLI 02-25-2025
  • GNW 02-19-2025
  • Dividend Yield
  • DNLI N/A
  • GNW N/A
  • EPS Growth
  • DNLI N/A
  • GNW N/A
  • EPS
  • DNLI N/A
  • GNW 0.20
  • Revenue
  • DNLI N/A
  • GNW $7,426,000,000.00
  • Revenue This Year
  • DNLI N/A
  • GNW N/A
  • Revenue Next Year
  • DNLI $420.35
  • GNW N/A
  • P/E Ratio
  • DNLI N/A
  • GNW $32.36
  • Revenue Growth
  • DNLI 204.74
  • GNW N/A
  • 52 Week Low
  • DNLI $14.56
  • GNW $5.67
  • 52 Week High
  • DNLI $33.33
  • GNW $7.90
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 35.14
  • GNW 38.77
  • Support Level
  • DNLI $19.93
  • GNW $6.82
  • Resistance Level
  • DNLI $21.64
  • GNW $7.10
  • Average True Range (ATR)
  • DNLI 0.96
  • GNW 0.16
  • MACD
  • DNLI -0.06
  • GNW -0.04
  • Stochastic Oscillator
  • DNLI 21.56
  • GNW 22.00

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About GNW Genworth Financial Inc

Genworth Financial is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. most of the revenue is generated by the Long-Term Care Insurance segment. The company earns most of its revenue in the United States.

Share on Social Networks: